• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带因子V莱顿纯合子的女性发生妊娠相关静脉血栓栓塞的风险。

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

作者信息

Middeldorp S, Libourel E J, Hamulyák K, Van der Meer J, Büller H R

机构信息

Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x.

DOI:10.1046/j.1365-2141.2001.02766.x
PMID:11380431
Abstract

The risk of venous thromboembolism (VTE) is increased in pregnancy and during the post-partum period. The absolute risk for pregnancy-related VTE in heterozygous women with the factor V Leiden mutation is approximately 2%, but studies on this risk for homozygous women show conflicting results. In a retrospective family study, we found that the risk of pregnancy-related VTE in women with a symptomatic first-degree relative was 17% per pregnancy (95%CI 4.7-37.4). Anticoagulant prophylaxis during the post-partum period appears to be indicated in asymptomatic homozygous women from symptomatic kindred, whereas this could be decided on an individual basis during pregnancy.

摘要

孕期及产后静脉血栓栓塞(VTE)风险增加。携带因子V莱顿突变的杂合子女性发生与妊娠相关VTE的绝对风险约为2%,但关于纯合子女性这一风险的研究结果相互矛盾。在一项回顾性家族研究中,我们发现有症状的一级亲属的女性每妊娠一次发生与妊娠相关VTE的风险为17%(95%可信区间4.7-37.4)。产后期间,对于来自有症状家族的无症状纯合子女性似乎应进行抗凝预防,而在孕期则可根据个体情况决定是否进行预防。

相似文献

1
The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.携带因子V莱顿纯合子的女性发生妊娠相关静脉血栓栓塞的风险。
Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x.
2
Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.严重遗传性易栓症携带者妊娠相关静脉血栓形成的风险
Thromb Haemost. 2001 Sep;86(3):800-3.
3
Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.合并杂合子因子V莱顿(FVL)和凝血酶原(FII)20210A突变以及单独杂合子FII单基因突变的妊娠相关静脉血栓栓塞症(VTE)
Br J Haematol. 2003 Oct;123(2):327-34. doi: 10.1046/j.1365-2141.2003.04582.x.
4
Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.凝血因子V莱顿突变与孕妇静脉血栓栓塞风险
Haematologica. 2001 Dec;86(12):1305-9.
5
[Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].[遗传性杂合子因子V莱顿和/或因子II基因突变女性的妊娠相关静脉血栓形成]
Bull Acad Natl Med. 2004;188(8):1377-93; discussion 1393-6.
6
[The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].[伴有莱顿突变的女性在妊娠和产褥期静脉血栓栓塞的发生率]
Ceska Gynekol. 2005 Mar;70(2):133-8.
7
Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.口服避孕药会增加纯合子型凝血因子V莱顿突变女性在年轻时出现静脉血栓临床表现的风险。
Br J Haematol. 1996 May;93(2):487-90. doi: 10.1046/j.1365-2141.1996.5712013.x.
8
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.杂合子和纯合子因子 V 莱顿突变携带者之间的静脉血栓栓塞事件和复发风险是否真的不同?一项回顾性队列研究。
Eur J Intern Med. 2016 May;30:77-81. doi: 10.1016/j.ejim.2016.02.023. Epub 2016 Mar 9.
9
Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.有妊娠和产褥期血栓形成病史女性的凝血酶原和因子V突变
N Engl J Med. 2000 Feb 10;342(6):374-80. doi: 10.1056/NEJM200002103420602.
10
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden.凝血因子V莱顿纯合子女性的妊娠相关静脉血栓栓塞风险及妊娠结局
Hematol J. 2000;1(1):37-41. doi: 10.1038/sj.thj.6200005.

引用本文的文献

1
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.美国血液学会 2018 年静脉血栓栓塞症管理指南:妊娠相关静脉血栓栓塞症。
Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.
2
Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold.妊娠期和产褥期静脉血栓栓塞症的预防:跨越门槛。
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):160-167. doi: 10.1182/asheducation-2017.1.160.
3
Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.
妊娠、血栓形成倾向与首次静脉血栓形成风险:系统评价与贝叶斯荟萃分析
BMJ. 2017 Oct 26;359:j4452. doi: 10.1136/bmj.j4452.
4
Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.血栓形成倾向的遗传风险因素以及妊娠和产褥期静脉血栓栓塞的概率。
Blood. 2016 Nov 10;128(19):2343-2349. doi: 10.1182/blood-2016-03-703728. Epub 2016 Sep 9.
5
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.产科相关静脉血栓栓塞症的治疗与预防指南。
J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0.
6
The role of thrombophilia in pregnancy.血栓形成倾向在妊娠中的作用。
Thrombosis. 2013;2013:516420. doi: 10.1155/2013/516420. Epub 2013 Dec 18.
7
Pulmonary embolism in pregnancy.妊娠期肺栓塞
J Thromb Thrombolysis. 2014 Apr;37(3):251-70. doi: 10.1007/s11239-013-0941-9.
8
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.纯合子因子 V Leiden 突变和因子 V Leiden 与凝血酶原突变的双重杂合性。
J Thromb Thrombolysis. 2013 Oct;36(3):324-31. doi: 10.1007/s11239-012-0824-5.
9
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.静脉血栓栓塞症、血栓形成倾向、抗血栓治疗与妊娠:《抗血栓治疗与血栓预防,第 9 版:美国胸科医师学会循证临床实践指南》。
Chest. 2012 Feb;141(2 Suppl):e691S-e736S. doi: 10.1378/chest.11-2300.
10
Evidence-based approach to thrombophilia testing.基于证据的血栓形成倾向检测方法。
J Thromb Thrombolysis. 2011 Apr;31(3):275-81. doi: 10.1007/s11239-011-0572-y.